| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970746 | The Journal of Heart and Lung Transplantation | 2012 | 9 Pages |
Abstract
First-line treatment of severe pre-capillary pulmonary hypertension with sub-cutaneous treprostinil is safe and efficacious over many years. If up-titration beyond 6 months is tolerated, effective doses are reached and outcomes are good.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Roela MD, Nika MD, Daniel MD, Diana MD, Michael PhD, Walter MD, Jutta MSc, Johannes PhD, Irene M. MD,